The relation between QRS amplitude and left ventricular mass in patients with hypertension identified at screening

Ljuba Bacharova1, Oleg V Baum, Galina A Muromtseva

  • 1International Laser Center, Bratislava, Slovak Republic. bacharova@ilc.sk

Insights

The specific potential of myocardium (SP) is a more sensitive indicator of early cardiac remodeling in hypertension than traditional measures. This parameter can detect changes even before left ventricular hypertrophy is clinically apparent.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Hypertension Research

Background:

  • Hypertension is a major risk factor for cardiac target organ damage.
  • Left ventricular hypertrophy (LVH) is a common consequence of hypertension, but early signs of myocardial remodeling may precede its clinical detection.
  • Assessing early cardiac changes in hypertensive patients without overt LVH is crucial for timely intervention.

Purpose of the Study:

  • To investigate the relationship between QRS amplitude and left ventricular mass (LVM) in hypertensive patients.
  • To identify novel markers for early detection of myocardial remodeling in hypertension, particularly in individuals without clinical LVH.
  • To evaluate the utility of the specific potential of myocardium (SP) as an indicator of early hypertrophic remodeling.

Main Methods:

  • Electrocardiograms were used to calculate the maximum QRS spatial vector magnitude (QRSmax).
  • Left ventricular mass (LVM) was assessed using echocardiography.
  • The specific potential of myocardium (SP) was computed as the ratio of QRSmax to LVM.
  • The study included healthy subjects and hypertensive patients, with a focus on a subgroup free of LVH.

Main Results:

  • Hypertensive subjects exhibited higher LVM but significantly lower QRSmax and SP values compared to healthy individuals.
  • Even in the LVH-free subgroup, hypertensive patients showed significantly lower SP values.
  • These findings were independent of age and body mass index differences between groups.

Conclusions:

  • The specific potential of myocardium (SP) is a more sensitive parameter for evaluating early hypertrophic remodeling than the separate assessment of LVM and QRS voltage.
  • SP can detect early myocardial remodeling in hypertensive subjects even before signs of cardiac target organ involvement are evident by current clinical classifications.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...